Medical Device Registration at ANVISA in Brazil
On demand workshop of international registration
Regulation of Medical Device in Brazil
Brazil is a biggest Latin American country with population of over 200 Mio. residents. The medical device market has an attractive potential, however with complex regulatory requirements. Brazil's current medical device market worth is approximately
$10.5 billion and
imported medical devices account for
80 percen t of the market (
Meddeviceonline ).
The authority of medical device is
Agência Nacional de Vigilância Sanitária (ANVISA). Besides monitoring
medical device , ANVISA is also responsible for Pesticides, Food, Cosmetics, Pharmacies and Drugstores, Pharmaceutical supplies, Medicines, Ports, Airports and Borders, Sanitarians, Blood, Tissues and Organs, Tabaco.
The
main task of ANVISA is to promote the protection of the population’s health by executing sanitary control of the production, marketing and use of products and services subject to health regulation, including related environments, processes, ingredients and technologies, as well as the control in ports, airports and borders.
Actually ANVISA keeps the Brazilian regulatory framework up-to-date at international level. In 2012 it co-founded the
International Medical Device Regulators Forum (IMDRF) .
The most important
legislatives are listed below:
•Law No. 6360/1976
•Decree No. 8077/2013, DECRETO - Health Surveillance
•Decree No. 79.094/1977, Classification and Registration Requirements for Medical Products
•RDC 751/2022 (replacing RDC 185/2021), Medical Device Registration
•RDC 211/2018, GMP for manufacturers of Medical Devices Resolution
•RDC 665/2022 (Replacing RDC RDC 16/2013), GMP Requirements for Medical Devices and IVDs
•RDC 40/2015, Cadastro Registration Requirements of Medical Devices
•RDC 687/2022 (replacing RDC 183/2017), Administrative processes applicable for granting GMP Certification for manufacturers of Medical Devices (Risk Classes III and IV)
•RDC 56/2001, Safety and Efficacy Requirements
•RDC 67/2009 and Resolution RDC 23/11, Post market surveillance
Prerequiste of Product Registration at ANVISA
The
home country approval is not needed for medical device registration at ANVISA. However, the approval in
EU, US, Japan, Australia and Canada can leverage the review process by Brazilian authority.
You need a
Brazilian agent who has a business licence in Brazil and communicates with ANVISA in
Portuguese.
Then you have to achieve
Brazil Good Manufacturing Practice (GMP Certification) in prior to product registration of class III and IV medical device. Please be aware that the
MDSAP certificate acts as only
a good reference
to accelerate GMP CERTIFICATION approval, however it doesn’t replace it.
Brazilian agent
It is also called
Brazilian Registration Holder (BRH). The role is very similar to US agent and
Chinese agent of medical device and IVD.
To simplify sales activities of
medical device in Brazil, an
excellent solution is the hosting of registration with help of BRH. With Hosting Service, your company could submit product dossier benefiting sound regulatory affairs experience, without
establishing a subsidiary in Brazil and get all licenses required by ANVISA. It also
reduces time and cost without binding often to
economic oriented distributors
as BRH.
With hosting service,
product registration will be issued on behalf of
a third consulting party that has no sales activity, but only
hosts registration and
provides an import authorization for any distributors designated by manufacturers.
With hosting service, the manufacturers will have full control over
product technical documents, so host is just a third contracted part because the rights are contractually limited to manufacturer.
The
Brazilian Registration Holder
will be responsible for maintaining the registration during its life time, and the manufacturers and its appointed distributors will have exclusive use of this record and service.
Product classification
In accordance with
RDC 751/2022 chapter II there are there are four classes of medical device in Brazil,
I, II, III and IV
(see
Table 1). Very similar to Annex VIII Classification rules at
MDR in Europe there are
22 classification rules pursuant to
RDC
751/2022
in Brazil. Brazilian class I and IV medical device can be equivalently respectively seen as European class I and III under rough comparison. And Brazilian class II and III medical device corresponds to
European class IIa and IIb.
If medical device manufacturers are unsure about classification, a system to
apply for determination of classification of medical device
can be used at ANVISA.
Notificação means
abbreviated registration. It applied to
class I and II medical device. From class III to IV there is a more complex registration process called
Registro with more documents, GMP certification and often
other certifications.
Table 1: Classification and type of registration of medical device in Brazil
The product certificate of class I and II medical device
doesn’t expire. The product certificate of class III and IV medical device is
10 years
valid in Brazil.
Registration process of Medical Device in Brazil
Based on product classification the following registration process is illustrated: